Pretreatment with rh-GMCSF, but not rh-IL3, enhances PAF-induced eosinophil accumulation in guinea-pig airways

Br J Pharmacol. 1990 Jul;100(3):399-400. doi: 10.1111/j.1476-5381.1990.tb15817.x.

Abstract

Intraperitoneal injections of recombinant human granulocyte-macrophage colony stimulating factor (rh-GMCSF, 50 micrograms/kg-1 daily) or interleukin-3 (rh-IL3, 50 micrograms kg-1 daily) for two days, induced an increase in the percentage of bone marrow and pulmonary airway eosinophils in the guinea-pig. In addition, rh-IL3-treated animals exhibited an increase (21%) in blood neutrophils. Exposure of guinea-pigs to an aerosol of platelet activating factor (PAF) gives rise to a selective pulmonary eosinophil accumulation, maximal at 48 h. The eosinophilic response to PAF was significantly enhanced in rh-GMCSF-treated guinea-pigs but was suppressed in rh-IL3-treated animals.

MeSH terms

  • Aerosols
  • Animals
  • Bronchoalveolar Lavage Fluid / cytology
  • Colony-Stimulating Factors / pharmacology*
  • Eosinophils / drug effects*
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Growth Substances / pharmacology*
  • Guinea Pigs
  • In Vitro Techniques
  • Interleukin-3 / pharmacology*
  • Platelet Activating Factor / administration & dosage
  • Platelet Activating Factor / pharmacology*
  • Recombinant Proteins / pharmacology

Substances

  • Aerosols
  • Colony-Stimulating Factors
  • Growth Substances
  • Interleukin-3
  • Platelet Activating Factor
  • Recombinant Proteins
  • Granulocyte-Macrophage Colony-Stimulating Factor